The efficacy and safety of the recommended intramuscular (im) clinical doses of xylazine-ketamine (5mg-35mg/kg), diazepam-ketamine (5mg-60mg/kg) and acepromazine-ketamine (5mg-75mg/kg) post administration were obtained, evaluated and compared using the following parameters in 10 apparently healthy rabbits: vital parameters (means of heart rates, respiratory rates and temperature), onset of loss of righting reflex, onset of analgesia, duration of analgesia, duration at recumbency and attempts to stand. Onset of loss of righting reflex was not significantly different (p>0.05) with xylazine-ketamine, diazepam-ketamine and acepromazine-ketamine at 3.4±0.3, 2.0±0.0 and 2.6±0.3 minutes respectively. Diazepam-ketamine and acepromazine-ketamine showed no analgesia while xylazine-ketamine had onset of analgesia and duration of analgesia of 4.2±0.1 and 57.0±0.7 minutes respectively. Duration of recumbency and first attempt to stand were longest with diazepam-ketamine, intermediate with acepromazine-ketamine and shortest with xylazine-ketamine of 184.4±3.3 and 42.0±1.4; 169.9±3.0 and 26.6±1.7; and 62±1.5 and 11.2±0.9 minutes respectively. Mean heart rate ranged between 173.2±6.6 to 187.2±7.5; 188.6±6.4 to 206.0±3.1 and 190.8±1.3 to 202.8±1.9 beats/minute with xylazine-ketamine, diazepam-ketamine, and acepromazine-ketamine respectively. Mean respiratory rate ranges were 58.4±3.5 to 133.0±11.2; 71.4±6.9 to 121.2±12.6 and 80.8±6.2 to 137.0±4.3 breaths/minute with xylazine-ketamine, diazepamketamine and acepromazine-ketamine respectively. Mean temperature ranges were 39.9±0.1 to 40.0±0.1; 39.0±0.3 to 39.9±0.1 and 39.6±0.1 to 40.2±0.0 : C with xylazine-ketamine, diazepam-ketamine and acepromazineketamine respectively. In conclusion, all the three ketamine drug combinations produced unconsciousness and immobility, but only xylazine-ketamine provided additional analgesia. They were associated with normal heart rate and rectal temperature, as well as polypnoea of some clinical concern. Only xylazine-ketamine is potentially useful for painful procedures. Addition of specific analgesics to diazepam-ketamine and acepromazine-ketamine may make them useful for painful procedures.
Introduction
Considering that inhalant anaesthetic delivery apparatus can cause practical problems in the rabbit, injectable anaesthesia involving ketamine combinations is currently popular in this species (Flecknell, 2009) . In this regard, ketamine is often combined with an alpha-2-agonist (e.g. xylazine), a benzodiazepine (e.g. diazepam) or a phenothiazine tranquilliser (e.g. acepromazine) to enhance muscle relaxation and analgesia and prolong duration of effect (Muir, 1985) . However, the sedatives in use with ketamine are associated with side effects that are of concern. Xylazine produces respiratory depression in most animals, and bradycardia, bradyarrhythmias and hypotension are observed depending on species and dose (Short, 1987) . Diazepam is associated with species and occasional individual variability in response and its solvent (propylene glycol) may produce hypotension (Short, 1987) . Acepromazine has prolonged duration of effect and is associated with hypotension secondary to marked peripheral vasodilation and response variability (Hall et al, 2001) . Besides, rabbits have been reported to be the third most commonly anaesthetized species, but have at least seven times more risks of anaestheticrelated deaths compared to dogs and cats (Brodbelt, 2009) . Inspite of the popularity of these three ketamine drug combinations, a comparative study of their relative efficacy and safety is yet to be reported in the rabbit. The aim of this study, therefore, was to compare using rabbits the relative efficacy and safety of xylazine-ketamine (XK), diazepam-ketamine (DK) and acepromazine-ketamine (AK) at their respective intramuscular (im) doses recommended for clinical use. Selected anaesthetic indices and associated changes in heart rate (HR), respiratory rate (RR) and rectal temperature (RT) were determined at 10-min intervals in the first hour of anaesthesia.
Materials and methods
Experimental animals 10 apparently healthy adult New Zealand x American Chinchilla, rabbits of both sexes (four intact bucks and six intact does) weighing 1.8 ± 0.2kg (mean ± sem) and acquired from the Experimental Animal Unit of the Faculty of Veterinary Medicine, University of Ibadan, Ibadan were used for the study. The rabbits were housed in pairs in cages and fed ad libitum mainly on commercial pelletized rabbit feed supplemented with freshly cut leaves of Tridax (Tridax procumbens), sweet potato (Ipomea batatas) and water leaf (Talinum trianuglare). Drinkable water was also provided ad libitum.
Study protocol
Each of the ten rabbits underwent three anaesthetic protocols (treatment) on three different occasions with one week interval allowed in between treatments. The anaesthetic protocols were designated as xylazine-ketamine (XK), acepromazineketamine (AK) and diazepam-ketamine (DK). Rabbits were premedicated the first time with xylazine (Chanazene ®, Chanelle laboratories (20mg/ml) at a dose rate of 5mg/kg body weight; the second time with diazepam (Valium 20®, Roche products Ltd, Welywn garden city, U.K, 5mg/ml) and the third time with acepromazine (Beruce®, Berk pharmaceuticals ltd, Eastburne, England, 10mg/ml).Thirty minutes after premedication, each time anaesthesia was induced with ketamine (Non-proprietary; Rotexmedia Lab, Trittau Germany,50mg/ml) at a dose rate of 35mg/kg when premedicated with xylazine (XK); 60mg/kg when premedicated with diazepam (DK) and 75mg/kg when premedicated with acepromazine (AK).
All drugs were administered through the intrasmuscular route and dosages employed were as recommended by White & Holmes (1976) , Lipman et al (1990) , and Wixison (1994) . The time of induction was recorded. Immediately after induction of anaesthesia, analgesia was assessed using the pedal withdrawal reflex. The hind paws were pinched with a pair of haemostatic forceps closed to the first ratchet at 2 min intervals and the time the rabbit was noticed not to withdraw the hind limbs in response to the pinch (loss of pedal reflex) was recorded. This pinching of the paws was continued at two minutes interval until the time when the rabbit started to withdraw the hind limbs in response to the paw pinch. This time was recorded as time of return of pedal reflex. Following the loss of the righting reflex by the anaesthetized rabbits, they were placed on right lateral recumbency on a padded wooden table. between the assumption of sternal and standing postures by the anaesthetized rabbit.
Calculated anaesthetic indices

Measured physiological parameters
In the course of each trial, heart rates (HR), respiratory rates (RR) and rectal temperature (RT) were determined immediately after the injection of ketamine, and thereafter, at 10 minutes intervals over the first 60 minutes of anaesthesia. Heart rate (in beats/min) was determined with the aid of a precordial stethoscope placed over the left second and fifth intercostal spaces, respiratory rate (in breaths /min) was determined by observation of the rabbit's thoracic excursions and rectal temperature (in :C) was determined using a digital clinical thermometer.
Analysis of data
All data recorded were calculated as means ± standard error of means (sem) of 10 rabbits. The means of OLRR, OA, DA, DR and ATS for XK, DK and AK were compared using one way ANOVA followed by Bonferrom t procedure when a significant difference was indicated. The mean values of the measured physiological parameters were compared using analysis of variance (ANOVA) for repeated measures followed as appropriate by Dunnett's test when a significant difference was indicated. A value of P < 0.05 was considered statistically significant for all the comparisons (Dawson & Trapps, 2004) .
Results
The anaesthetic indices for the three drug combinations are shown in 
Discussion
Of the three drug combinations studied, only XK produced analgesia. This antinociceptive effect of XK cannot be ascribed to the action of the administered ketamine alone, since its use in combination with either diazepam or acepromazine even at respective higher doses of 60mg/kg or 75mg/kg than 35mg/kg with xylazine, produced no demonstrable analgesic effect. Certainly, xylazine must have contributed to, and potentiated the analgesic action of ketamine in The production of analgesia by XK in our study is consistent with findings of similar studies (White & Holmes, 1976; Green et al, 1981; Lipman et al, 1990; Kazemi, 2002; Kilic, 2004) . However, some workers despite using higher doses of xylazine-ketamine than the doses used in our study, reported lack of analgesia in all the rabbits studied (Amarpal et al, 2010) while others reported analgesia in only a few of the rabbits studied for only a short period (Henke et al, 2005) . This low level of analgesia demonstrated by rabbits in these other studies compared with ours despite their use of higher dosages of xylazine-ketamine may be due to the breed and strain variations of the rabbits used. Indeed, it has been observed that rabbits display wide inter-individual variability in response to anaesthetics and show strain and sex specific differences (Avsaroglu et al., 2003) . The production of anaesthesia by XK in our study implies that in real clinical situation only XK is useful for painful procedures. Nonetheless, it may also be possible to extend the use of DK and AK to painful procedures with the addition of specific analgesic agents to them. Our finding of lack of analgesia with the DK combination is in agreement with the findings of Green et al (1981) and Kazemi (2002) where DK produced good sedation and muscular relaxation but not enough analgesia to do surgery.
Whereas in this study, AK did not produce analgesia, half of the rabbits given AK by Amarpal and others (2010) showed analgesia. This discrepancy may also be attributed to breed and strain variations of the rabbits used. However, as with our study, Kazemi (2002) also reported lack of analgesia with acepromazine-ketamine. It is interesting to record longer duration of recumbency with both DK and AK than with XK. This finding may relate partly to the higher im doses of ketamine used in DK (60mg / kg) and AK (75mg/kg) than in XK (35mg/kg). Prolonged muscle relaxing effects of diazepam and acepromazine, as well as the absence of surgical stimulation on the experimental rabbits, might also have contributed to the prolonged duration of recumbency. The ranges of mean HR recorded for the three ketamine drug combinations are within the normal range of 130 to 325 beats / min accepted for the awake, resting rabbits (Harkness & Wagner, 1995) making the anaesthetic regimes safe for clinical use. Mean RR associated with XK, DK and AK showed large variations as well as increases that could be described as polypnoea. The cause of the observed polypnoea in the anaesthetised rabbits is not known. The fast, panting breathing may reflect an attempt by the anaesthetised, recumbent rabbit to maintain minute volume or simply a response to hypercapnia and /or hypoxia. However, the latter supposition could not be confirmed as no blood gas analysis was carried out in the present study. Mean RT recorded for the three ketamine drug combinations are within the normal range of 38.5 to 40.0 0 C quoted for awake, resting rabbits (Harkness & Wagner, 1995) . In conclusion, all the three ketamine drug combinations produced unconsciousness and immobility, but only XK provided additional analgesia. They were associated with normal HR and RT, as well as polypnoea of some clinical concern. Only XK is potentially useful for painful procedures. It may be possible to extend the use of DK and AK to painful procedures with the further addition of specific analgesic agents to them.
